Lipids

ApoA-1

 

  1. Alberga AS, Prud'homme D, Kenny GP, Goldfield GS, Hadjiyannakis S, Gougeon R, Phillips P, Malcolm J, Wells G, Doucette S, Ma J, Sigal RJ. Effects of aerobic and resistance training on abdominal fat, apolipoproteins and high-sensitivity C-reactive protein in adolescents with obesity: the HEARTY randomized clinical trial. Int J Obes (Lond). 2015 Oct;39(10):1494-500. doi: 10.1038/ijo.2015.133. Epub 2015 Jul 23. PubMed PMID: 26202452.

  2. Aryan Z, Afarideh M, Ghajar A, Esteghamati S, Esteghamati A, Nakhjavani M. Conflicting interactions of apolipoprotein A and high density lipoprotein cholesterol with microvascular complications of type 2 diabetes. Diabetes Res Clin Pract. 2017 Nov;133:131-141. doi: 10.1016/j.diabres.2017.07.037. Epub 2017 Sep 1. PubMed PMID: 28934670.

  3. Bale BF, Doneen AL. The Bale/Doneen Method: Paradigm Shift in CVD Prevention. Preceptorship Course; 2018 March 09; Las Vegas, Nevada, United States of America.

  4. Chung JO, Park SY, Han JH, Cho DH, Chung DJ, Chung MY. Serum apolipoprotein A-1 concentrations and the prevalence of cardiovascular autonomic neuropathy in individuals with type 2 diabetes. J Diabetes Complications. 2018 Apr;32(4):357-361. doi: 10.1016/j.jdiacomp.2018.01.006. Epub 2018 Jan 31. PubMed PMID: 29453140.

  5. Gille A, D'Andrea D, Tortorici MA, Hartel G, Wright SD. CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients. Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):953-963. doi: 10.1161/ATVBAHA.118.310538. Epub 2018 Feb 8. PubMed PMID: 29437574.

  6. Theodorou AA, Panayiotou G, Volaklis KA, Douda HT, Paschalis V, Nikolaidis MG, Smilios I, Toubekis A, Kyprianou D, Papadopoulos I, Tokmakidis SP. Aerobic, resistance and combined training and detraining on body composition, muscle strength, lipid profile and inflammation in coronary artery disease patients. Res Sports Med. 2016 Jul-Sep;24(3):171-84. doi: 10.1080/15438627.2016.1191488. Epub 2016 Jun 3. PubMed PMID: 27258806.

  7. Thorning TK, Raziani F, Bendsen NT, Astrup A, Tholstrup T, Raben A. Diets with high-fat cheese, high-fat meat, or carbohydrate on cardiovascular risk markers in overweight postmenopausal women: a randomized crossover trial. Am J Clin Nutr. 2015 Sep;102(3):573-81. doi: 10.3945/ajcn.115.109116. Epub 2015 Jul 15. PubMed PMID: 26178720.

  8. Zhang M, Zhao GJ, Yin K, Xia XD, Gong D, Zhao ZW, Chen LY, Zheng XL, Tang XE, Tang CK. Apolipoprotein A-1 Binding Protein Inhibits Inflammatory Signaling Pathways by Binding to Apolipoprotein A-1 in THP-1 Macrophages. Circ J. 2018 Apr 3. doi: 10.1253/circj.CJ-17-0877. [Epub ahead of print] PubMed PMID: 29618705.

ApoB-100

 

  1. Alberga AS, Prud'homme D, Kenny GP, Goldfield GS, Hadjiyannakis S, Gougeon R, Phillips P, Malcolm J, Wells G, Doucette S, Ma J, Sigal RJ. Effects of aerobic and resistance training on abdominal fat, apolipoproteins and high-sensitivity C-reactive protein in adolescents with obesity: the HEARTY randomized clinical trial. Int J Obes (Lond). 2015 Oct;39(10):1494-500. doi: 10.1038/ijo.2015.133. Epub 2015 Jul 23. PubMed PMID: 26202452.

  2. AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices., Cole TG, Contois JH, Csako G, McConnell JP, Remaley AT, Devaraj S, Hoefner DM, Mallory T, Sethi AA, Warnick GR. Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices. Clin Chem. 2013 May;59(5):752-70. doi: 10.1373/clinchem.2012.196733. Epub 2013 Feb 5. Erratum in: Clin Chem. 2013 Aug;59(8):1275. PubMed PMID: 23386699.

  3. Bale BF, Doneen AL. The Bale/Doneen Method: Paradigm Shift in CVD Prevention. Preceptorship Course; 2018 March 09; Las Vegas, Nevada, United States of America.

  4. Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. [Internet]. Washington, D.C.: National Academies Press; 2005. 941. Available from: https://www.nal.usda.gov/sites/default/files/fnic_uploads/energy_full_report.pdf. DOI: https://doi.org/10.17226/10490.

  5. Karasek D, Vaverkova H, Cibickova L, Gajdova J, Kubickova V. Apolipoprotein B vs non-high-density lipoprotein cholesterol: Association with endothelial hemostatic markers and carotid intima-media thickness. J Clin Lipidol. 2017 Mar - Apr;11(2):442-449. doi: 10.1016/j.jacl.2017.01.020. Epub 2017 Feb 10. PubMed PMID: 28502501.

  6. Olsen T, Vinknes KJ, Svingen GFT, Pedersen ER, Tell GS, Blomhoff R, Drevon CA, Ueland PM, Midttun Ø, Refsum H, Nygård OK. Cardiovascular disease risk associated with serum apolipoprotein B is modified by serum vitamin A. Atherosclerosis. 2017 Oct;265:325-330. doi: 10.1016/j.atherosclerosis.2017.07.020. Epub 2017 Jul 21. PubMed PMID: 28774484.

LDL Particle Number & Small LDL Paricle Number

  1. Bale BF, Doneen AL. The Bale/Doneen Method: Paradigm Shift in CVD Prevention. Preceptorship Course; 2018 March 09; Las Vegas, Nevada, United States of America.

  2. Barbosa KB, Volp AC, Hermsdorff HH, Navarro-Blasco I, Zulet MÁ, Martínez JA, Bressan J. Relationship of oxidized low density lipoprotein with lipid profile and oxidative stress markers in healthy young adults: a translational study. Lipids Health Dis. 2011 Apr 19;10:61. doi: 10.1186/1476-511X-10-61. PubMed PMID: 21504598; PubMed Central PMCID: PMC3110141.

  3. Ho HV, Sievenpiper JL, Zurbau A, Blanco Mejia S, Jovanovski E, Au-Yeung F, Jenkins AL, Vuksan V. The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials. Br J Nutr. 2016 Oct;116(8):1369-1382. Epub 2016 Oct 11. Review. PubMed PMID: 27724985.

  4. Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. [Internet]. Washington, D.C.: National Academies Press; 2005. 941. Available from: https://www.nal.usda.gov/sites/default/files/fnic_uploads/energy_full_report.pdf. DOI: https://doi.org/10.17226/10490.

  5. Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003 Dec;26(12):3215-8. PubMed PMID: 14633804.

  6. Pichler G, Amigo N, Tellez-Plaza M, Pardo-Cea MA, Dominguez-Lucas A, Marrachelli VG, Monleon D, Martin-Escudero JC, Ascaso JF, Chaves FJ, Carmena R, Redon J. LDL particle size and composition and incident cardiovascular disease in a South-European population: The Hortega-Liposcale Follow-up Study. Int J Cardiol. 2018 Mar 29. pii: S0167-5273(17)37884-1. doi: 10.1016/j.ijcard.2018.03.128. [Epub ahead of print] PubMed PMID: 29628276.

  7. Rasmiena AA, Barlow CK, Ng TW, Tull D, Meikle PJ. High density lipoprotein efficiently accepts surface but not internal oxidized lipids from oxidized low-density lipoprotein. Biochim Biophys Acta. 2016 Feb;1861(2):69-77. doi: 10.1016/j.bbalip.2015.11.002. Epub 2015 Nov 10. PubMed PMID: 26569052.

Triglycerides (TG)

 

  1. Bale BF, Doneen AL. The Bale/Doneen Method: Paradigm Shift in CVD Prevention. Preceptorship Course; 2018 March 09; Las Vegas, Nevada, United States of America.

  2. Li XX, Zhao Y, Huang LX, Xu HX, Liu XY, Yang JJ, Zhang PJ, Zhang YH. Effects of smoking and alcohol consumption on lipid profile in male adults in northwest rural China. Public Health. 2018 Apr;157:7-13. doi: 10.1016/j.puhe.2018.01.003. Epub 2018 Feb 17. PubMed PMID: 29459348.

  3. Pilz S, Gaksch M, Kienreich K, Grübler M, Verheyen N, Fahrleitner-Pammer A, Treiber G, Drechsler C, Ó Hartaigh B, Obermayer-Pietsch B, Schwetz V, Aberer F, Mader J, Scharnagl H, Meinitzer A, Lerchbaum E, Dekker JM, Zittermann A, März W, Tomaschitz A. Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial. Hypertension. 2015 Jun;65(6):1195-201. doi: 10.1161/HYPERTENSIONAHA.115.05319. Epub 2015 Mar 23. PubMed PMID: 25801871.

  4. Ramos VW, Batista LO, Albuquerque KT. Effects of fructose consumption on food intake and biochemical and body parameters in Wistar rats. Rev Port Cardiol. 2017 Dec;36(12):937-941. doi: 10.1016/j.repc.2017.04.003. Epub 2017 Dec 6. English, Portuguese. PubMed PMID: 29221682.

  5. Unger G, Benozzi SF, Perruzza F, Pennacchiotti GL. Triglycerides and glucose index: a useful indicator of insulin resistance. Endocrinol Nutr. 2014 Dec;61(10):533-40. doi: 10.1016/j.endonu.2014.06.009. Epub 2014 Aug 28. English, Spanish. PubMed PMID: 25174769.

  6. Vallejo-Vaz AJ, Fayyad R, Boekholdt SM, Hovingh GK, Kastelein JJ, Melamed S, Barter P, Waters DD, Ray KK. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the Treating to New Targets (TNT) Trial. Circulation. 2018 Apr 4. pii: CIRCULATIONAHA.117.032318. doi: 10.1161/CIRCULATIONAHA.117.032318. [Epub ahead of print] PubMed PMID: 29618599.

Total Cholesterol

 

  1. Arnal N, Morel GR, de Alaniz MJ, Castillo O, Marra CA. Role of copper and cholesterol association in the neurodegenerative process. Int J Alzheimers Dis. 2013;2013:414817. doi: 10.1155/2013/414817. Epub 2013 Oct 29. PubMed PMID: 24288650; PubMed Central PMCID: PMC3830777.

  2. Bale BF, Doneen AL. The Bale/Doneen Method: Paradigm Shift in CVD Prevention. Preceptorship Course; 2018 March 09; Las Vegas, Nevada, United States of America.

  3. Barbosa KB, Volp AC, Hermsdorff HH, Navarro-Blasco I, Zulet MÁ, Martínez JA, Bressan J. Relationship of oxidized low-density lipoprotein with lipid profile and oxidative stress markers in healthy young adults: a translational study. Lipids Health Dis. 2011 Apr 19;10:61. doi: 10.1186/1476-511X-10-61. PubMed PMID: 21504598; PubMed Central PMCID: PMC3110141.

  4. Lidin M, Hellénius ML, Rydell-Karlsson M, Ekblom-Bak E. Long-term effects on cardiovascular risk of a structured multidisciplinary lifestyle program in clinical practice. BMC Cardiovasc Disord. 2018 Apr 2;18(1):59. doi: 10.1186/s12872-018-0792-6. PubMed PMID: 29609555; PubMed Central PMCID: PMC5879543.

  5. Silva BSA, Lira FS, Rossi FE, Ramos D, Uzeloto JS, Freire APCF, de Lima FF, Gobbo LA, Ramos EMC. Inflammatory and Metabolic Responses to Different Resistance Training on Chronic Obstructive Pulmonary Disease: A Randomized Control Trial. Front Physiol. 2018 Mar 23;9:262. doi: 10.3389/fphys.2018.00262. eCollection 2018. PubMed PMID: 29628896; PubMed Central PMCID: PMC5877487.

  6. Zang X, Huang H, Zhuang Z, Chen R, Xie Z, Xu C, Mo X. The association between serum copper concentrations and cardiovascular disease risk factors in children and adolescents in NHANES. Environ Sci Pollut Res Int. 2018 Apr 6. doi: 10.1007/s11356-018-1816-6. [Epub ahead of print] PubMed PMID: 29623647.

Low Density Lipid (LDL) - Calculated

 

  1. Bale BF, Doneen AL. The Bale/Doneen Method: Paradigm Shift in CVD Prevention. Preceptorship Course; 2018 March 09; Las Vegas, Nevada, United States of America.

  2. Barbosa KB, Volp AC, Hermsdorff HH, Navarro-Blasco I, Zulet MÁ, Martínez JA, Bressan J. Relationship of oxidized low density lipoprotein with lipid profile and oxidative stress markers in healthy young adults: a translational study. Lipids Health Dis. 2011 Apr 19;10:61. doi: 10.1186/1476-511X-10-61. PubMed PMID: 21504598; PubMed Central PMCID: PMC3110141.

  3. Ho HV, Sievenpiper JL, Zurbau A, Blanco Mejia S, Jovanovski E, Au-Yeung F, Jenkins AL, Vuksan V. The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials. Br J Nutr. 2016 Oct;116(8):1369-1382. Epub 2016 Oct 11. Review. PubMed PMID: 27724985.

  4. Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. [Internet]. Washington, D.C.: National Academies Press; 2005. 941. Available from: https://www.nal.usda.gov/sites/default/files/fnic_uploads/energy_full_report.pdf. DOI: https://doi.org/10.17226/10490.

  5. Pichler G, Amigo N, Tellez-Plaza M, Pardo-Cea MA, Dominguez-Lucas A, Marrachelli VG, Monleon D, Martin-Escudero JC, Ascaso JF, Chaves FJ, Carmena R, Redon J. LDL particle size and composition and incident cardiovascular disease in a South-European population: The Hortega-Liposcale Follow-up Study. Int J Cardiol. 2018 Mar 29. pii: S0167-5273(17)37884-1. doi: 10.1016/j.ijcard.2018.03.128. [Epub ahead of print] PubMed PMID: 29628276.

  6. Rasmiena AA, Barlow CK, Ng TW, Tull D, Meikle PJ. High density lipoprotein efficiently accepts surface but not internal oxidized lipids from oxidized low-density lipoprotein. Biochim Biophys Acta. 2016 Feb;1861(2):69-77. doi: 10.1016/j.bbalip.2015.11.002. Epub 2015 Nov 10. PubMed PMID: 26569052.

Direct High Density Lipid (HDL) Cholesterol

 

  1. Bale BF, Doneen AL. The Bale/Doneen Method: Paradigm Shift in CVD Prevention. Preceptorship Course; 2018 March 09; Las Vegas, Nevada, United States of America.

  2. Inonu Koseoglu H, Pazarli AC, Kanbay A, Demir O. Monocyte Count/HDL Cholesterol Ratio and Cardiovascular Disease in Patients With Obstructive Sleep Apnea Syndrome: A Multicenter Study. Clin Appl Thromb Hemost. 2018 Jan;24(1):139-144. doi: 10.1177/1076029616677803. Epub 2016 Nov 11. PubMed PMID: 27837155.

  3. Mohammadi H, Djalali M, Daneshpazhooh M, Honarvar NM, Chams-Davatchi C, Sepandar F, Fakhri Z, Yaghubi E, Zarei M, Javanbakht MH. Effects of L-carnitine supplementation on biomarkers of oxidative stress, antioxidant capacity and lipid profile, in patients with pemphigus vulgaris: a randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr. 2017 Aug 23. doi: 10.1038/ejcn.2017.131. [Epub ahead of print] PubMed PMID: 28832573.

  4. Sercelik A, Besnili AF. Increased monocyte to high-density lipoprotein cholesterol ratio is associated with TIMI risk score in patients with ST-segment elevation myocardial infarction. Rev Port Cardiol. 2018 Mar 31. pii: S0870-2551(17)30189-0. doi: 10.1016/j.repc.2017.06.021. [Epub ahead of print] English, Portuguese. PubMed PMID: 29615294.

  5. Silva BSA, Lira FS, Rossi FE, Ramos D, Uzeloto JS, Freire APCF, de Lima FF, Gobbo LA, Ramos EMC. Inflammatory and Metabolic Responses to Different Resistance Training on Chronic Obstructive Pulmonary Disease: A Randomized Control Trial. Front Physiol. 2018 Mar 23;9:262. doi: 10.3389/fphys.2018.00262. eCollection 2018. PubMed PMID: 29628896; PubMed Central PMCID: PMC5877487.

Non-HDL (High Density Lipid) Cholesterol

 

  1. Bale BF, Doneen AL. The Bale/Doneen Method: Paradigm Shift in CVD Prevention. Preceptorship Course; 2018 March 09; Las Vegas, Nevada, United States of America.

  2. Barbosa KB, Volp AC, Hermsdorff HH, Navarro-Blasco I, Zulet MÁ, Martínez JA, Bressan J. Relationship of oxidized low density lipoprotein with lipid profile and oxidative stress markers in healthy young adults: a translational study. Lipids Health Dis. 2011 Apr 19;10:61. doi: 10.1186/1476-511X-10-61. PubMed PMID: 21504598; PubMed Central PMCID: PMC3110141.

  3. Ho HV, Sievenpiper JL, Zurbau A, Blanco Mejia S, Jovanovski E, Au-Yeung F, Jenkins AL, Vuksan V. The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials. Br J Nutr. 2016 Oct;116(8):1369-1382. Epub 2016 Oct 11. Review. PubMed PMID: 27724985.

  4. Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. [Internet]. Washington, D.C.: National Academies Press; 2005. 941. Available from: https://www.nal.usda.gov/sites/default/files/fnic_uploads/energy_full_report.pdf. DOI: https://doi.org/10.17226/10490.

  5. Rasmiena AA, Barlow CK, Ng TW, Tull D, Meikle PJ. High density lipoprotein efficiently accepts surface but not internal oxidised lipids from oxidised low density lipoprotein. Biochim Biophys Acta. 2016 Feb;1861(2):69-77. doi: 10.1016/j.bbalip.2015.11.002. Epub 2015 Nov 10. PubMed PMID: 26569052.

  6. Wang D, Wang L, Wang Z, Chen S, Ni Y, Jiang D. Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis. Lipids Health Dis. 2018 Apr 3;17(1):67. doi: 10.1186/s12944-018-0720-x. PubMed PMID: 29615042.

Large VLDL-P, VLDL Size, & LP-IR Score

 

  1. Bale BF, Doneen AL. The Bale/Doneen Method: Paradigm Shift in CVD Prevention. Preceptorship Course; 2018 March 09; Las Vegas, Nevada, United States of America.

  2. Gharib M, Tao H, Fungwe T, Hajri T. Very low density lipoprotein receptor deficiency prevents obesity-induced cardiac lipotoxicity. J Biol Chem. 2018 Apr 9. pii: jbc.M117.813303. doi: 10.1074/jbc.M117.813303. [Epub ahead of print] PubMed PMID: 29632065.

  3. Ghonimy A, Zhang DM, Farouk MH, Wang Q. The Impact of Carnitine on Dietary Fiber and Gut Bacteria Metabolism and Their Mutual Interaction in Monogastrics. Int J Mol Sci. 2018 Mar 28;19(4). pii: E1008. doi: 10.3390/ijms19041008. Review. PubMed PMID: 29597260.

  4. Jiang ZG, de Boer IH, Mackey RH, Jensen MK, Lai M, Robson SC, Tracy R, Kuller LH, Mukamal KJ. Associations of insulin resistance, inflammation and liver synthetic function with very low-density lipoprotein: The Cardiovascular Health Study. Metabolism. 2016 Mar;65(3):92-9. doi: 10.1016/j.metabol.2015.10.017. Epub 2015 Oct 22. PubMed PMID: 26892520; PubMed Central PMCID: PMC4761104.

  5. Lucero D, Miksztowicz V, Macri V, López GH, Friedman S, Berg G, Zago V, Schreier L. Overproduction of altered VLDL in an insulin-resistance rat model: Influence of SREBP-1c and PPAR-α. Clin Investig Arterioscler. 2015 Jul-Aug;27(4):167-74. doi: 10.1016/j.arteri.2014.11.002. Epub 2015 Mar 18. PubMed PMID: 25796423.

  6. Mosher PE, Ferguson MA, Arnold RO. Lipid and lipoprotein changes in premenstrual women following step aerobic dance training. Int J Sports Med. 2005 Oct;26(8):669-74. PubMed PMID: 16158373.

  7. Sarzynski MA, Burton J, Rankinen T, Blair SN, Church TS, Després JP, Hagberg JM, Landers-Ramos R, Leon AS, Mikus CR, Rao DC, Seip RL, Skinner JS, Slentz CA, Thompson PD, Wilund KR, Kraus WE, Bouchard C. The effects of exercise on the lipoprotein subclass profile: A meta-analysis of 10 interventions. Atherosclerosis. 2015 Dec;243(2):364-72. doi: 10.1016/j.atherosclerosis.2015.10.018. Epub 2015 Oct 17. PubMed PMID: 26520888; PubMed Central PMCID: PMC4663138.

  8. Shalaurova I, Connelly MA, Garvey WT, Otvos JD. Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistance. Metab Syndr Relat Disord. 2014 Oct;12(8):422-9. doi: 10.1089/met.2014.0050. Epub 2014 Jun 24. PubMed PMID: 24959989; PubMed Central PMCID: PMC4175429.

© Myrna's Clinical Nutrition designed by Myrna Haag